Study of over 3.5m patients with 1 of 24 most common primary, malignant, invasive neoplasms between 1996-2013 found little evidence of direct impact of national cancer strategies on 1-year survival, ...

Following request from European Medicines Agency, SPC has been updated to include information regarding possible interaction between sunitinib and other medicinal products that are inhibitors of the...